Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
Abroad (travel likely)RecruitingPHASE2
Conditions
Bladder Cancer · Muscle-Invasive Bladder Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York, New York, United States
Contact: Study coordinator (Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 212-305-5098
Study leads
Alexander Z Wei, MD
Principal Investigator
Columbia University